title: Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?
authors.affiliation: Department of Leukemia, University of Texas MD Anderson Cancer, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: fravandi@mdanderson.org.
authors.forename: Farhad
authors.initials: F
authors.lastname: Ravandi
authors.affiliation: Department of Leukemia, University of Texas MD Anderson Cancer, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use*; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D010087:Oxides / Q000627:therapeutic use*; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D015255:Idarubicin